NCT03493789 - Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 13, 2018

Primary Completion Date

March 19, 2019

Study Completion Date

March 19, 2019

Conditions

Stage I Lung CancerStage I Non-Small Cell Lung Cancer AJCC v7Stage IA Non-Small Cell Lung Carcinoma AJCC v7Stage IB Non-Small Cell Lung Carcinoma AJCC v7Stage II Lung CancerStage II Non-Small Cell Lung Cancer AJCC v7Stage IIA Non-Small Cell Lung Carcinoma AJCC v7Stage IIB Non-Small Cell Lung Carcinoma AJCC v7

Interventions

DRUG

Fludeoxyglucose F-18

Given IV

PROCEDURE

Positron Emission Tomography (PET)

Undergo FDG-PET

RADIATION

Stereotactic Body Radiation Therapy (SBRT)

Undergo SBRT

Trial Locations (1)

30322

Emory University Hospital/Winship Cancer Institute, Atlanta